Uncategorized
SERI Lugano: ParaCel Riboflavin Selected by FDA for Epi-on Cross-Linking for Keratoconus
LUGANO, Switzerland--(BUSINESS WIRE)--ParaCel riboflavin invented by Dr. Roberto Pinelli, released to AVEDRO in 2011, has been chosen among others by the FDA for a new epi-on crosslinking.